Demis Hassabis’ AI company raises $5 billion, months after he left as Google DeepMind CEO
Isomorphic Labs is looking to develop new medicines using AI.

TL;DR
- Isomorphic Labs, an AI drug discovery startup, raised $5 billion in a Series C funding round.
- The company was founded by Demis Hassabis, who recently stepped down as CEO of Google DeepMind.
- The funding will support the design and development of new medicines using AI.
- The round was co-led by Greenoaks and Sequoia Capital, with investment from Alphabet.
- Drug discovery startups have seen record funding in 2026, with $23.2 billion raised.
- Isomorphic is building a proprietary AI-powered drug design engine and therapeutic pipeline.